Retrieve available abstracts of 14 articles: HTML format
Single Articles
September 2025
DA SILVA FER, Yucel A, Menezes APM, Ruiz AC, et al Mechanisms Underlying Treatment-Resistant Depression: Exploring Sex-Based
Biological Differences.
J Neurochem. 2025;169:e70215. PubMedAbstract available
August 2025
BORGES DE SOUZA P, Rodrigues ALS, De Felice FG Shared Mechanisms in Dementia and Depression: The Modulatory Role of Physical
Exercise.
J Neurochem. 2025;169:e70185. PubMedAbstract available
July 2025
CUSSOTTO S, Colle R, Voican CS, Ciocan DM, et al The Gut Microbiota Is Altered in Antidepressant-Free Depressed Patients and Is
Associated With Depression Severity.
J Neurochem. 2025;169:e70173. PubMedAbstract available
January 2025
ARDILES NM, Tapia-Cuevas V, Estay SF, Alcaino A, et al Increased forebrain EAAT3 expression confers resilience to chronic stress.
J Neurochem. 2025;169:e16216. PubMedAbstract available
September 2024
KAVAKBASI E, Sampson E, Mills NT, Hori H, et al Inflammation-stratified augmentation of vortioxetine with celecoxib: Results from
a double-blind, randomized, placebo-controlled trial in major depressive
disorder.
J Neurochem. 2024;168:1817-1825. PubMedAbstract available
July 2024
HOJGAARD K, Kaadt E, Mumm BH, Pereira VS, et al Dysregulation of circadian clock gene expression patterns in a
treatment-resistant animal model of depression.
J Neurochem. 2024 Jul 5. doi: 10.1111/jnc.16172. PubMedAbstract available
June 2024
GONZALEZ PM, Jenkins AR, LaMalfa KS, Kangas BD, et al Chronic ecologically relevant stress effects on reverse-translated touchscreen
assays of reward responsivity and attentional processes in male rats:
Implications for depression.
J Neurochem. 2024 Jun 24. doi: 10.1111/jnc.16157. PubMedAbstract available
March 2024
BREMSHEY S, Gross J, Renken K, Masseck OA, et al The role of serotonin in depression-A historical roundup and future directions.
J Neurochem. 2024 Mar 13. doi: 10.1111/jnc.16097. PubMedAbstract available
ZHAO Y, Wan J, Li Y Genetically encoded sensors for in vivo detection of neurochemicals relevant to
depression.
J Neurochem. 2024 Mar 11. doi: 10.1111/jnc.16046. PubMedAbstract available
FARINHA-FERREIRA M, Magalhaes DM, Neuparth-Sottomayor M, Rafael H, et al Unmoving and uninflamed: Characterizing neuroinflammatory dysfunction in the
Wistar-Kyoto rat model of depression.
J Neurochem. 2024 Mar 2. doi: 10.1111/jnc.16083. PubMedAbstract available
January 2024
ABE Y, Erchinger VJ, Ousdal OT, Oltedal L, et al Neurobiological mechanisms of electroconvulsive therapy for depression: Insights
into hippocampal volumetric increases from clinical and preclinical studies.
J Neurochem. 2024 Jan 18. doi: 10.1111/jnc.16054. PubMedAbstract available
August 2023
PIECHOTA M, Hoinkis D, Korostynski M, Golda S, et al Gene expression profiling in whole blood stimulated ex vivo with
lipopolysaccharide as a tool to predict post-stroke depressive symptoms:
Proof-of-concept study.
J Neurochem. 2023;166:623-632. PubMedAbstract available
July 2023
LEWIS V, Rodrigue B, Arsenault E, Zhang M, et al Translational control by ketamine and its implications for comorbid cognitive
deficits in depressive disorders.
J Neurochem. 2023;166:10-23. PubMedAbstract available
March 2023
CHENG S, Wang W, Zhu Z, Zhao M, et al Involvement of brain-derived neurotrophic factor methylation in the prefrontal
cortex and hippocampus induced by chronic unpredictable mild stress in male mice.
J Neurochem. 2023;164:624-642. PubMedAbstract available